Endocrine effects of danazol in menstruating women.
This work proposes and verifies an accurate and efficient formulation of broadband time-domain impedance boundary conditions for locally-reacting surfaces within the time-domain nodal discontinuous Galerkin method.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (26)
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. 1991
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes 1991
- A clinical trial using danazol for the treatment of premenstrual tension 1987
- Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells 1986
- Endocrine consequences of danazol treatment in menorrhagia 1986
- Inhibitory effects of danazol on steroidogenesis in cultured human granulosa cells 1986
- Ultrastructural changes in endometriotic tissue during danazol treatment 1985
- Short‐term effects of danazol on endometrial histology 1984
- Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women 1984
- In vitro effect of danazol on steroidogenesis in developing human follicles 1984
- THE INTERACTION OF HUMAN ENDOMETRIAL AND MYOMETRIAL STEROID RECEPTORS WITH DANAZOL 1983
- Absence of effect of danazol on estrogen-induced luteinizing hormone release from rat hypothalamo-pituitary axis in vitro 1983
- Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle 1982
- Dynamic tests of hypothalamic and pituitary function in women treated with danazol 1982
- Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero 1981
- Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment 1981
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness 1981
- Successful treatment of D-penicillamine-induced breast gigantism with danazol. 1981
- Treatment of pulmonary endometriosis with danazol 1981
- Competitive inhibition by Danazol of oestradiol binding to rabbit and ovine uterine oestradiol receptor 1980
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative 1980
- Mechanism of induction of luteal phase defects by danazol 1980
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT 1979
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* 1979
- Effect of danazol on estradiol-17β and progesterone secretion by porcine ovarian cells in vitro 1979
- Effects of Danazol on Pituitary Gonadotrophins in Post‐Menopausal Women 1978
Source provenance
- openalex
- last seen: 2026-05-10T10:11:54.490404+00:00